Human Fetus in the Womb at 22 Weeks (Black Skin)

Description

A fetus of approximately 22 weeks gestation lies in a flexed, left-side-presenting attitude within the amniotic cavity, head low and trunk curved so that the knees and hands approach the chest and face. The rendering shows the smooth, thinly keratinised fetal skin with underlying vascularity giving the characteristic reddish translucency of the mid second trimester, along with a formed external ear, closed eyelids, distinct digits of the hand and separated toes on the foot. Behind the fetal back, the placenta is seen in profile as a discoid organ with a richly branched chorionic vascular pattern on its fetal surface, and the umbilical cord passes from the placental insertion toward the fetal abdomen, partly obscured by the flexed limbs. The uterine wall and myometrial vessels form the surrounding chamber, with pale bands suggesting the amnion and decidual surface. Twenty-two weeks sits at the threshold of viability, making this stage central to obstetric counselling, and it corresponds to the period when detailed anomaly scanning, biometric assessment of biparietal diameter, femur length and abdominal circumference, and Doppler evaluation of umbilical cord flow are routinely performed. The visible relationship between placental site, cord insertion and fetal lie underpins discussion of placental localisation, cord entanglement, oligohydramnios and intrauterine growth restriction. Skin maturity at this stage also explains the fragility and insensible fluid loss encountered in extremely preterm neonates. The image supports obstetric and midwifery teaching on second-trimester development, prenatal ultrasound courses that pair schematic anatomy with sonographic appearances, and embryology chapters tracing week-by-week growth as part of this gestational series. It is equally suited to antenatal patient education, maternity apps and editorial or public-health figures explaining fetal development and placental function. Anatomical accuracy verified by SciePro's Medical Advisory Board.